Caption Management, LLC Biotechnology

Caption Management, LLC

  • $8.03 Billion
  • Q2 2025

Stock List

Stock Option Type Value Options Held Last Trade Trade History
EYPT
Eye Point Pharmaceuticals, Inc.
PUT
$2.07 Million
220K
Q2 2025
New holding
OCUL
Ocular Therapeutix, Inc
PUT
$2.05 Million
221K
Q2 2024
New holding
AUPH
Aurinia Pharmaceuticals Inc.
PUT
$2.04 Million
241K
Q2 2025
Added 18.38%
TRVI
Trevi Therapeutics, Inc.
CALL
$2.01 Million
368K N/A
LQDA
Liquidia Corp
CALL
$1.97 Million
159K
Q2 2025
New holding
ARGX
Argenx Se
PUT
$1.93 Million
3.5K
Q2 2024
New holding
NUVB
Nuvation Bio Inc.
CALL
$1.88 Million
965K N/A
ARVN
Arvinas, Inc.
CALL
$1.74 Million
236K
Q2 2025
Added 2008.37%
MRUS
Merus N.V.
CALL
$1.58 Million
30K
Q2 2025
New holding
NVAX
Novavax Inc
CALL
$1.54 Million
245K
Q1 2025
New holding
PTCT
Ptc Therapeutics, Inc.
CALL
$1.47 Million
30K
Q2 2024
New holding
PTCT
Ptc Therapeutics, Inc.
PUT
$1.47 Million
30K
Q2 2024
New holding
CRSP
Crispr Therapeutics Ag
PUT
$1.46 Million
30K
Q1 2025
Reduced 86.76%
BMRN
Biomarin Pharmaceutical Inc
CALL
$1.4 Million
25.5K
Q3 2024
New holding
LEGN
Legend Biotech Corp
CALL
$1.3 Million
36.6K
Q4 2024
New holding
RZLT
Rezolute, Inc.
CALL
$1.27 Million
285K
Q2 2025
Added 100.39%
ALT
Altimmune, Inc.
CALL
$1.25 Million
323K
Q2 2025
Added 2423.62%
MREO
Mereo Biopharma Group PLC
CALL
$1.19 Million
438K
Q2 2025
Added 88.58%
IDYA
Ideaya Biosciences, Inc.
PUT
$1.16 Million
55K
Q2 2025
New holding
ARCT
Arcturus Therapeutics Holdings Inc.
CALL
$1.14 Million
87.9K
Q4 2024
New holding
TGTX
Tg Therapeutics, Inc.
CALL
$1.13 Million
31.5K
Q3 2023
New holding
RVMD
Revolution Medicines, Inc.
PUT
$1.1 Million
30K
Q4 2024
New holding
CYTK
Cytokinetics Inc
PUT
$951,000
28.8K
Q2 2025
Reduced 67.65%
TRVI
Trevi Therapeutics, Inc.
PUT
$820,000
150K N/A
RNA
Avidity Biosciences, Inc.
PUT
$766,000
27K
Q4 2024
New holding
TVTX
Travere Therapeutics, Inc.
PUT
$740,000
50K
Q2 2024
Added 66.66%
ARVN
Arvinas, Inc.
PUT
$736,000
100K
Q2 2025
Added 2008.37%
URGN
Uro Gen Pharma Ltd.
CALL
$685,000
50K N/A
BMRN
Biomarin Pharmaceutical Inc
PUT
$659,000
12K
Q3 2024
New holding
ACAD
Acadia Pharmaceuticals Inc
PUT
$647,000
30K
Q2 2025
Reduced 87.04%
ACAD
Acadia Pharmaceuticals Inc
CALL
$647,000
30K
Q2 2025
Reduced 87.04%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$632,000
40K
Q2 2025
Added 104.68%
KYMR
Kymera Therapeutics, Inc.
PUT
$632,000
14.5K
Q2 2025
New holding
NVAX
Novavax Inc
PUT
$630,000
100K
Q1 2025
New holding
PRTA
Prothena Corp Public LTD CO
PUT
$607,000
100K
Q2 2025
New holding
CRNX
Crinetics Pharmaceuticals, Inc.
CALL
$575,000
20K
Q1 2025
New holding
VRDN
Viridian Therapeutics, Inc.\De
CALL
$559,000
40K
Q4 2024
New holding
KMPH
Kempharm, Inc
PUT
$494,000
100K
Q1 2025
New holding
OCUL
Ocular Therapeutix, Inc
CALL
$463,000
50K
Q2 2024
New holding
ETNB
89bio, Inc.
CALL
$392,000
40K
Q2 2025
Reduced 36.66%
CNTA
Centessa Pharmaceuticals PLC
CALL
$388,000
29.6K
Q1 2025
New holding
BEAM
Beam Therapeutics Inc.
CALL
$382,000
22.5K
Q2 2025
New holding
AUPH
Aurinia Pharmaceuticals Inc.
CALL
$381,000
45K
Q2 2025
Added 18.38%
ARCT
Arcturus Therapeutics Holdings Inc.
PUT
$375,000
28.9K
Q4 2024
New holding
NTLA
Intellia Therapeutics, Inc.
CALL
$328,000
35K
Q1 2025
Reduced 76.95%
NTLA
Intellia Therapeutics, Inc.
PUT
$328,000
35K
Q1 2025
Reduced 76.95%
FOLD
Amicus Therapeutics, Inc.
CALL
$286,000
50K
Q2 2025
Reduced 94.28%
DAWN
Day One Biopharmaceuticals, Inc.
CALL
$260,000
40K
Q1 2025
New holding
GOSS
Gossamer Bio, Inc.
CALL
$258,000
210K
Q2 2025
New holding
Filter Shares Options
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email